NINTEDANIB MEPHA caps moll 150 mg 60 pce

7680697470022 CH-69747 L01EX09 03.99.0.

Active substances:

No images available

Details

Product number
6974702
CPT
-
Packaging group
60
Unit
Kapsel(n)
Composition
nintedanibum 150 mg ut nintedanibi esilas 156.62 mg, triglycerida media, adeps solidus, polyglyceroli-3 dioleas, Kapselhülle: gelatina, glycerolum (85 per centum), E 171, E 172 (rubrum), E 172 (flavum), aqua purificata, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, pro capsula.

Articles (1)

Nintedanib-Mepha 150 mg, Weichkapseln
Weichkapseln
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/12/2025
Patient information leaflet
Français
22/12/2025
Patient information leaflet
Italien
22/12/2025
Professional SmPC
Allemand
22/12/2025
Professional SmPC
Français
22/12/2025
Professional SmPC
Italien
22/12/2025

Detailed composition

Substance Quantity Type Category
nintedanibum
150.0 MG Substance Wirkstoff (Principe actif)
nintedanibi esilas
156.62 MG Substance WIZUS
triglycerida media
- Substance HNIDK
adeps solidus
- Substance HNIDK
polyglyceroli-3 dioleas
- Substance HNIDK
gelatina
- Substance HNIDK
glycerolum (85 per centum)
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
aqua purificata
- Substance HNIDK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Reimbursement information

Public price
CHF 665.40
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/01/2026

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
69747
Drug name
Nintedanib-Mepha, Weichkapseln
Galenic form
KAPWE
ATC Code
L01EX09
Authorization status
Z
Dispensation category
B
First authorization
14/08/2025
Authorization expiration date
13/08/2030
IT number
03.99.0.
Domain
Human medicine
Field of application
Idiopathische Lungenfibrose, interstitielle Lungenerkrankungen

Packaging details

Description (FR)
NINTEDANIB MEPHA caps moll 150 mg 60 pce
Description (DE)
NINTEDANIB MEPHA Weichkaps 150 mg 60 Stk
Market launch
21/12/2025
Narcotic (BTM)
No

Original drug

OFEV, Weichkapseln
CHF 1576.75
View original

Other packaging sizes

NINTEDANIB MEPHA caps moll 100 mg 60 pce
60 KAP
View
Buy us a coffee Explore the data